The 10-second takeaway
For the quarter ended March 31 (Q1), WebMD Health met expectations on revenues and missed expectations on earnings per share.
Compared to the prior-year quarter, revenue contracted significantly and GAAP earnings per share contracted to a loss.
Margins contracted across the board.
WebMD Health reported revenue of $106.9 million. The seven analysts polled by S&P Capital IQ expected revenue of $106.7 million on the same basis. GAAP reported sales were 19% lower than the prior-year quarter's $131.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.22. The seven earnings estimates compiled by S&P Capital IQ averaged -$0.13 per share. GAAP EPS were -$0.14 for Q1, versus $0.32 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 50%, 1,320 basis points worse than the prior-year quarter. Operating margin was -11.8%, 2,820 basis points worse than the prior-year quarter. Net margin was -7.3%, 2,220 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $123.1 million. On the bottom line, the average EPS estimate is $0.01.
Next year's average estimate for revenue is $506.8 million. The average EPS estimate is $0.11.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 111 members rating the stock outperform and 56 members rating it underperform. Among 49 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 30 give WebMD Health a green thumbs-up, and 19 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on WebMD Health is hold, with an average price target of $23.67.
New mobile devices and services are changing the game -- and profit potential -- at many former Internet leaders. Where does WebMD Health fit in? Who will lead going forward? Check out "3 Hidden Winners of the iPhone, iPad, and Android Revolution." Click here for instant access to this free report.
- Add WebMD Health to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.